FENOFIBRATE for Medulloblastoma recurrent: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 90 adverse event reports in the FDA FAERS database where FENOFIBRATE was used for Medulloblastoma recurrent.
Most Reported Side Effects for FENOFIBRATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myalgia | 411 | 7.2% | 177 | 61 |
| Dyspnoea | 373 | 6.5% | 220 | 109 |
| Fatigue | 365 | 6.4% | 187 | 95 |
| Asthenia | 356 | 6.2% | 204 | 122 |
| Dizziness | 356 | 6.2% | 202 | 71 |
| Fall | 354 | 6.2% | 219 | 123 |
| Drug ineffective | 326 | 5.7% | 30 | 110 |
| Pruritus | 325 | 5.7% | 213 | 31 |
| Nausea | 311 | 5.4% | 181 | 76 |
| Diarrhoea | 310 | 5.4% | 209 | 45 |
| Abdominal pain | 302 | 5.3% | 187 | 82 |
| Headache | 302 | 5.3% | 182 | 41 |
| Vomiting | 293 | 5.1% | 176 | 97 |
| Acute kidney injury | 285 | 5.0% | 44 | 217 |
| Decreased appetite | 283 | 5.0% | 196 | 61 |
Other Indications for FENOFIBRATE
Product used for unknown indication (2,027)
Dyslipidaemia (606)
Hypertriglyceridaemia (517)
Hyperlipidaemia (472)
Hypercholesterolaemia (286)
Blood triglycerides increased (196)
Blood cholesterol increased (149)
Lipids abnormal (68)
Blood cholesterol abnormal (67)
Medulloblastoma (67)
Other Drugs Used for Medulloblastoma recurrent
ETOPOSIDE (172)
CYCLOPHOSPHAMIDE (171)
TEMOZOLOMIDE (129)
BEVACIZUMAB (119)
IRINOTECAN (105)
THALIDOMIDE (95)
CELECOXIB (94)
CYTARABINE (70)
CISPLATIN (14)
VISMODEGIB (14)